Brief: Kiora Pharmaceuticals, Sentrx Animal Care Amend Existing Manufacturing Licensing Agreement For KIO-201
15/06/2023 22:30
June 15 (Reuters) - Kiora Pharmaceuticals Inc KPRX.O :
* KIORA PHARMACEUTICALS INC-CO AND SENTRX ANIMAL CARE AMEND
EXISTING MANUFACTURING LICENSING AGREEMENT FOR KIO-201
* KIORA PHARMACEUTICALS INC- AMENDMENT ELIMINATES $4.75M IN
NEAR-TERM MILESTONES KIORA WOULD HAVE OWED TO SENTRX
Further company coverage: KPRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiora Pharmaceuticals
See all newsKiora Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kiora Pharmaceuticals, Inc. expected to post a loss of 62 cents a share - Earnings Preview
Brief: Kiora Pharmaceuticals Inc - Enters Securities Purchase Agreement On April 3, 2026 - SEC Filing
Kiora Pharmaceuticals posts 2025 net loss as expenses rise
Brief: Kiora Pharmaceuticals Files For Mixed Shelf Offering Of Up To $100 Million- SEC Filing